team-subhead.jpg

Team

Our Mission of Discovery

At Halia Therapeutics we are discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.

Team

david-bearss.png

David J. Bearss, PhD

President and Chief Executive Officer

Paul Flynn, V.P. Development Operations.png

Paul Flynn

V.P. Development Operations

Andi Groen, Director of Operations.png

Andi Groen

Director of Operations

jared-bearss.png

Jared Bearss, MBA

Chief Operating Officer

Alexis Mollard, Senior Director Medicinal Chemistry.png

Alexis Mollard

Sr. Director Medicinal Chemistry

Devan Bursey, Scientist.png

Devan Bursey

Scientist

jeff-burton.png

Jeff Burton, CPA/MAcc

Chief Financial Officer

Josue Gonzalez, Senior Scientist.png

Josue Gonzalez

Senior Scientist

Taylor Avei, Lab Technician.png

Taylor Avei

Lab Technician

Partners

SG-logo-color.jpg
EU-logo-color.jpg
LD-logo-color.jpg
AS-logo-color.jpg